Methoxyamine Completed Phase 1 Trials for Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00692159Study of TRC102 in Combination With Pemetrexed in Cancer Patients